[1]李 航,郭伟丽,安 珍,等.PM2.5对慢性阻塞性肺疾病影响研究进展[J].新乡医学院学报,2016,33(3):234-238.[doi:10.7683/xxyxyxb.2016.03.020]
 LI Hang,GUO Weili,AN Zhen,et al.Research progress on the effect of PM2.5 on chronic obstructive pulmonary disease[J].Journal of Xinxiang Medical University,2016,33(3):234-238.[doi:10.7683/xxyxyxb.2016.03.020]
点击复制

PM2.5对慢性阻塞性肺疾病影响研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
33
期数:
2016年3
页码:
234-238
栏目:
综述
出版日期:
2016-03-05

文章信息/Info

Title:
Research progress on the effect of PM2.5 on chronic obstructive pulmonary disease
作者:
李 航1郭伟丽1安 珍1翟成凯2吴卫东1
(1.新乡医学院公共卫生学院,河南 新乡 453003;2.新乡市第一人民医院呼吸内科,河南 新乡 453000)
Author(s):
LI HangGUO WeiliAN ZhenZHAI ChenkaiWU Weidong
关键词:
细颗粒物慢性阻塞性肺疾病氧化应激炎症
分类号:
R563
DOI:
10.7683/xxyxyxb.2016.03.020
文献标志码:
A
摘要:
细颗粒物是指空气动力学直径≤2.5 μm的颗粒物质(PM2.5)。PM2.5表面可吸附有毒有害物质,且这些物质可以随呼吸作用沉积在肺泡,甚至可通过肺换气到达其他器官,对人体造成危害。PM2.5在呼吸道可诱发氧化应激、炎症反应和支气管上皮细胞的增生与纤维化,从而增加慢性阻塞性肺疾病的发病率及其发病时的症状。本文就近年来有关空气PM2.5对慢性阻塞性肺疾病发生和发展影响的研究进展进行概述。

参考文献/References:

[1] 赵英政,徐光翠,吴卫东.大气颗粒污染物对心血管系统的毒性作用及机制[J].新乡医学院学报,2015,32(2):96-100.
[2] 刘吉福.空气中悬浮颗粒物与呼吸系统疾病关系研究进展[J].环境与健康,2007,24(11):933-935.
[3] CHOI K S,INOUE S,SHINOZAAKI R.Air pollution,temperature,and regional differences in lung cancer mortality in Japan[J].Arch Environ Health,1997,52(3):160-168.
[4] OKONA M K B,BATTERSHILL J,BOOBIS A,et al.An approach to investigating the importance of high potency polycyclie aromatic hydrocarbons(PAHs) in the induction oflung cancer by air pollution[J].Food Chem Toxieol,2005,43(7):1103-1116.
[5] YAUK C,POLYZO A,ROWAN-CARROLL A,et al.Germ-line mutations,DNA damage,and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location[J].Proc Natl Acad Sci,2008,105(2):605-610.
[6] NELIN T D,JOSEPH A M,GORR M W,et al.Direct and indirect effects of particulate matter on the cardiovascular system[J].Toxicol Lett,2012,208(3):293-299.
[7] LOPEZ CAMPOS J L,TAN W,SORIANO J B.Global burden of COPD[J].Respirology,2016,21(1):14-23.
[8] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南:2013 年修订版[J].中华结核和呼吸杂志,2013,36(4):255-264.
[9] MANNINO D M,HOMA D M,AKINBAMI L J,et al.Chronic obstructive pulmonary disease surveillance-United States,1971-2000[J].MMWR Surveill Summ,2002,51(6):1-16.
[10] SIAFAKAS N I V I,VERMEIRE P,PRIDE N B,et al.Optimal assessment and management of chronic obstructive pulmonary disease(COPD)[J].Eur Respir J,1995,8(8):1398-1420.
[11] 中华人民共和国卫生部.2013中国卫生统计年鉴[M].北京:中国协和医科大学出版社,2013:295-376.
[12] 葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013:19-23.
[13] MANNINO D M,BUIST A S.Global burden of COPD:risk factors,prevalence,and future trends[J].Lancet,2007,370(9589):765-773.
[14] BLANC P D,IRIBARREN C,TRUPIN L,et al.Occupational exposures and the risk of COPD:dusty trades revisited[J].Thorax,2009,64(1):6-12.
[15] TZANAKIS N,ANAGNOSTOPOULOU U,FILADITAKI V,et al.Prevalence of COPD in Greece[J].Chest,2004,125(3):892-900.
[16] MCGHEE S M,HEDLEY A J,HO L M.Passive smoking and its impact oil employers and employees in Hang Kong[J].Oceup Environ Med,2002,59(12):842-846.
[17] LIU S,ZHOU Y,WANG X,et al.Biomass fuels are the probable risk factor for chronic obstractive plumonary disease in rural South China[J].Thorax,2007,62(10):889-897.
[18] MOOLGAVKAR S H.Air pollution and hospital admissions for chronic obstructive pulmonary disease in three metropolitan areas in the United states[J].Inhal Toxico,2000,12(14):75-90.
[19] 张金良,周瑾,谢绍东,等.北京市空气质量与每日居民死亡关系的研究[J].环境与健康杂志,2003,20(2):75-78.
[20] 洪秀琴,肖水源.慢性阻塞性肺病流行病学研究进展[J].中国医师杂志,2009,11(6):861-863.
[21] OBERDORSTER G,FERIN J,GELEIN R,et al.Role of the alveolar macrophage in lung injury:studies with ultrafine particles[J].Environ Health Perspect,1992,97:193-199.
[22] KREYLING W G.Intracellular particle dissolution in alveolar macrophages[J].Environ Health Perspect,1992,97:121-126.
[23] GEISER M.Morphological aspects of particle uptake by lung phagocytes[J].Microsc Res Tech,2002,57(6):512-522.
[24] ZHOU H,KODZIK L.Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae[J].Am J Respir Cell Mol Biol,2007,36(4):460-465.
[25] MACNEE W,DONALDSON K.Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD[J].Eur Respir J Suppl,2003,40:47s-51s.
[26] MORROW P E.Possible mechanisms to explain dust overloading of the lungs[J].Fundam Appl Toxicol,1988,10(3):369-384.
[27] VAN EEDEN S F,YEUNG A,QUINLAM K,et al.Systemic response to ambient particulate matter:relevance to chronic obstructive pulmonary disease[J].Proc Am Thorac Soc,2005,2(1):61-67.
[28] VAN EEDEN S F,TAN W C,SUWA T,et al.Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM10)[J].Am J Respir Crit Care Med,2001,164(5):826-830.
[29] CARTER J D,GHIO A J,SAMET J M,et al.Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent[J].Toxicol Appl Pharmacol,1997,146(2):180-188.
[30] MUNDANDHARA S D,BECKER S,MADDEN M C.Effects of diesel exhaust particles on human alveolar macrophage ability to secrete inflammatory mediators in response to lipopolysaccharide[J].Toxicol In Vitro,2006,20(5):614-624.
[31] AMAKAWA K,TERASHIMA T,MATSUZAKI T,et al.Suppressive effects of diesel exhaust particles on cytokine release from human and murine alveolar macrophages[J].Exp Lung Res,2003,29(3):149-164.
[32] YANG H M,BARGER M W,CASTRANOVA V,et al.Effects of diesel exhaust particles (DEP),carbon black,and silica on macrophage responses to lipopolysaccharide:evidence of DEP suppression of macrophage activity[J].J Toxicol Environ Health A,1999,58(5):261-278.
[33] BECKER S,SOUKUP J M.Decreased CD11b expression,phagocytosis,and oxidative burst in urban particulate pollution-exposed human monocytes and alveolar macrophages[J]. J Toxicol Environ Health A,1998,55(7):455-477.
[34] LING S H,VAN EEDEN S F.Particulate matter air pollution exposure:role in the development and exacerbation of chronic obstructive pulmonary disease[J].Int J Chron Obstruct Pulmon Dis,2009,4:233-243.
[35] TSAI S S,CHANG C C,YANG C Y.Fine particulate air pollution and hospital admissions for chronic obstructive pulmonarydisease:a case-crossover study in Taipei[J].Int J Environ Res Public Health,2013,10(11):6015-6026.
[36] 赵珂,曹军骥,文湘闽.西安市大气PM2.5污染与城区居民死亡率的关系[J].预防医学情报杂志,2011,27(4):257-262.
[37] ARACELI M E,YESSICA T R,Arturo F P,et al.Urban PM2.5 activates GAPDH and induces RBC damage in COPD patients[J].Front Biosci (Schol Ed),2013,5:638-649.
[38] 朱木林,袁云华,邓巍,等.慢性阻塞性肺疾病合并外周骨骼肌功能障碍患者炎性因子和代谢水平及线粒体功能的变化[J].新乡医学院学报,2015,32(5):412-414,418.
[39] AGUSTI A,EDWARDS L D,RENNARD S I,et al.Persistent systemic inflammation is associated with poor clinical outcomes in COPD:a novel phenotype[J].PLoS One,2012,7:e37483.
[40] THOMSEN M,INGEBRIGTSEN T S,MAROTT J L,et al.Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease[J].JAMA,2013,309:2353-2361.
[41] MAN S F,VAN EEDEN S,SIN D D.Vascular risk in chronic obstructive pulmonary disease:role of inflammation and other mediators[J].Can J Cardiol,2012,28(6):653-661.
[42] HOGG J C,CHU F,UTOKAPARCH S,et al.The nature of small-airway obstruction in chronic obstructive pulmonary disease[J].N Engl J Med,2004,350(26):2645-2653.
[43] LI Y,RITTENHOUSE-OLSON K,SCHEIDER W L,et al.Effect of particulate matter air pollution on C-reactive protein:a review of epidemiologic studies[J].Rev Environ Health,2012,27(2/3):133-149.
[44] PEACOCK J L,ANDERSON H R,BREMNER S A,et al.Outdoor air pollution and respiratory health in patients with COPD[J].Thorax,2011,66(7):591-596.
[45] MEHTA A J,SCHINDLER C,Perez L,et al.Acute respiratory health effects of urban air pollutants in adults with different patterns of underlying respiratory disease[J].Swiss Med Wkly,2012,142:w13681.
[46] PANGANIBAN R A,DAY R M.Hepatocyte growth factor in lung repair and pulmonary fibrosis[J].Acta Pharmacol Sin,2011,32(1):12-20.
[47] PALANGE P,TESTA U,HUERTAS A,et al.Circulating haemopoietic and endothelial progenitor cells are decreased in COPD[J].Eur Respir,2006,27(3):529-541.
[48] DADVAND P,NIEUWENHUIJSEN M J,AGUST A,et al.Air pollution and biomarkers of systemic inflammation and tissue repair in COPD[J].Eur Respir,2014,44(3):603-613.
[49] FEHRENBACH H.Alveolar epithelial type Ⅱ cell:defender of the alveolus revisited[J].Respir Res,2001,2(1):33-46.
[50] KIM K K,KUGLER M C,Wolters P J,et al.Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix[J].Proc Natl Acad Sci USA,2006,103(35):13180-13185.
[51] ARNOUX V,NASSOUR M,L′HELGOUALC′H A,et al.Erk5 controls Slug expression and keratinocyte activation during wound healing[J].Mol Biol Cell,2008,19(11):4738-4749.
[52] KATSOUYANNI K,TOULOUMI G,Samoli E,et al.Confounding and effect modification in the short-term effects of ambient particles on total mortality:results from 29 European cities within the APHEA2 project[J].Epidemiology,2001,12(5):521-531.
[53] BROWN A C,ROWE J A,BARKER T H.Guiding epithelial cell phenotypes with engineered integrin-specific recombinant fibronectin fragments[J].Tissue Eng Part A,2010,17(1/2):139-150.
[54] CAMARA J,JARAI G.Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha[J].Fibrogenesis Tissue Repair,2010,3(1):2.
[55] FELTON V M,BOROK Z,Willis B C.N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition[J].Physiol Lung Cell Mol Physiol,2009,297(5):L805-L812.
[56] GHARAEE-KERMANI M,HU B,PHAN S H,et al.Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis:focus on TGF-beta signaling and the myofibroblast[J].Curr Med Chem,2009,16(11):1400-1417.
[57] ZANOBETTI A,SCHWARTZ J,DOCKERY D W.Airborne particles are a risk factor for hospital admissions for heart and lung disease[J].Environ Health Perspect,2000,108(11):1071-1077.
[58] WILLIS B C,BOROK Z.TGF-beta-induced EMT:mechanisms and implications for fibrotic lung disease[J].Am J Physiol Lung Cell Mol Physiol,2007,293(3):L525-L534.
[59] DYSART M M,GALVIS B R,RUSSELL A G,et al.Environmental particulate (PM2.5) augments stiffness-induced alveolar epithelial cell mechanoactivation of transforming growth factor beta[J].PLoS One,2014,9(9):e106821.

相似文献/References:

[1]史册.慢性阻塞性肺疾病急性发作期的营养支持治疗[J].新乡医学院学报,2001,18(06):444.
[2]袁晓梅,孙 云,袁宇.慢性阻塞性肺疾病肺心病患者血浆内皮素测定的临床价值[J].新乡医学院学报,2002,19(04):273.
[3]郭志强.慢性阻塞性肺疾病60例院内获得性真菌感染与耐药性分析 [J].新乡医学院学报,2006,23(02):000.
[4]程思远.慢性阻塞性肺疾病继发真菌感染65例病原菌分布及耐药性分析[J].新乡医学院学报,2009,26(01):073.
[5]杨华,周志才,奚峰,等.无创正压通气治疗慢性阻塞性肺疾病急性加重期伴Ⅱ型呼吸衰竭[J].新乡医学院学报,2011,28(02):216.
[6]殷波,惠复新,赵寅滢,等.慢性阻塞性肺疾病急性加重期三重酸碱失衡与急性生理学和慢性健康状况评分Ⅲ评分及预后的关系 [J].新乡医学院学报,2011,28(03):346.
[7]刘金花,徐吟亚,付波.低分子肝素钙对慢性阻塞性肺疾病急性加重期患者血栓前状态的影响[J].新乡医学院学报,2012,29(09):680.
[8]王 沁,郭建辉,梁 栋,等.健脾益肺口服液对慢性阻塞性肺疾病“肺脾气虚证”大鼠动脉血气的影响[J].新乡医学院学报,2014,31(11):896.[doi:10.7683/xxyxyxb.2014.11.00]
[9]晋乐飞1,冯斐斐1,吴卫东. 大气细颗粒污染物对呼吸系统危害研究进展 [J].新乡医学院学报,2015,32(02):091.[doi:10.7683/xxyxyxb.2015.02.001]
[10]朱木林1,袁云华1,邓 巍2,等.慢性阻塞性肺疾病合并外周骨骼肌功能障碍患者炎性因子和代谢水平及线粒体功能的变化[J].新乡医学院学报,2015,32(05):412.

更新日期/Last Update: 2016-03-05